Showing results (831-840 of 16,169) with videos related to

Sort By:
Pageof 1,617
European Journal of Medicinal Chemistry|February 11, 2021
Structural basis for the design of bisubstrate inhibitors of protein kinase CK2 provided by complex structures with the substrate-competitive inhibitor heparinAlexander Schnitzler, Karsten Niefind
European Journal of Medicinal Chemistry|February 14, 2021
Design, synthesis and inhibitory activity of novel 2, 3-dihydroquinolin-4(1H)-one derivatives as potential succinate dehydrogenase inhibitorsWei Cheng, Yingkun Yan, Tingting Xiao, et al.
European Journal of Medicinal Chemistry|February 14, 2021
Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligandsZdeněk Dvořák, Karolína Poulíková, Sridhar Mani
European Journal of Medicinal Chemistry|September 25, 2019
Exploration of the antibiotic potentiating activity of indolglyoxylpolyaminesMelissa M Cadelis, Elliot I W Pike, Weirong Kang, et al.
European Journal of Medicinal Chemistry|September 25, 2019
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquineRaffaella Catalano, Roberta Rocca, Giada Juli, et al.
European Journal of Medicinal Chemistry|January 14, 2021
Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomasMelissa Santi, Ana Katrina Mapanao, Lorenzo Biancalana, et al.
European Journal of Medicinal Chemistry|February 26, 2021
Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activityMeng-Xue Wei, Jia-Ying Yu, Xin-Xin Liu, et al.
European Journal of Medicinal Chemistry|February 26, 2021
Medulloblastoma drugs in development: Current leads, trials and drawbacksJiachen Wen, M Kyle Hadden
European Journal of Medicinal Chemistry|February 27, 2021
A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activitiesJuan Wang, Boqiang Liang, Yiling Chen, et al.
European Journal of Medicinal Chemistry|February 28, 2021
Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitorsBin Zhang, Zhikun Liu, Shengjin Xia, et al.
Pageof 1,617